Wilson John Robert

CIK 00017555692 companiesJACKSONVILLE, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001755569

Recent Transactions

29 trades

Award
Marker Therapeutics, Inc.$MRKR
Stock Option (right to buy)
2023-06-06+8,000→ 8,000 total
Award
Marker Therapeutics, Inc.$MRKR
Stock Option (Right to Buy)
2022-05-24+80,000→ 80,000 total
Award
Marker Therapeutics, Inc.$MRKR
Common Stock
2021-06-08+12,658→ 7,812,008 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2021-05-25+22,500→ 22,500 total
Purchase
Marker Therapeutics, Inc.$MRKR
Common Stock
2021-03-16$1.75/sh+1,714,285→ 7,799,350 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-11$31.63/sh−2,308→ 5,412,953 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-11$30.87/sh−10,188→ 5,415,261 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-11$31.63/sh−769→ 3,164,954 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-11$30.87/sh−3,397→ 3,165,723 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-10$31.59/sh−25,256.25→ 5,426,349 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-10$30.93/sh−28,402.75→ 5,451,605.25 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-10$30.93/sh−9,467.25→ 3,177,838.75 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-10$31.59/sh−8,418.75→ 3,169,420 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-10$32.31/sh−300→ 3,169,120 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-10$32.31/sh−900→ 5,425,449 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-09$31.30/sh−17,480→ 3,197,475 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-09$31.30/sh−52,440→ 5,510,514 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-09$31.70/sh−10,169→ 3,187,306 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-09$31.70/sh−30,506→ 5,480,008 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-12-16−3,214,955→ 0 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-12-16+3,214,955→ 3,214,955 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Series A-3 Convertible Preferred Stock
2020-08-03−4,745,943→ 0 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Series A-3 Convertible Preferred Stock
2020-08-03−3,499,001→ 0 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-08-03+3,184,758→ 3,214,955 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-08-03+2,347,999→ 5,562,954 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2020-07-29+22,500→ 22,500 total
Award
Marker Therapeutics, Inc.$MRKR
Common Stock
2020-05-19+17,022→ 6,085,065 total
Award
Marker Therapeutics, Inc.$MRKR
Common Stock
2019-05-09+7,260→ 6,068,043 total
Award
Marker Therapeutics, Inc.$MRKR
Non-Employee Director Stock Option (Right to Buy)
2018-10-17+12,500→ 12,500 total

Companies

Recent Filings

Address

5 WEST FORSYTH STREET, SUITE 200

JACKSONVILLE, FL, 32202

View on SEC.gov